Maybe, instead of bickering, name calling
and running to "mum", we can get back
to evaluating and summising the potential
of what has the makings of a very important
Australian bio-tech company.
I certainly don't see this coming week as
make or break, not by a long way.
If 3m walk, there is more than one other
potential partner.
GSK
Beckitt Reckinser
Johnson and Johnson
lan
just to name a few
I can't wait to see the future if this company
develop, and hope for not a take over, but
multiple partnerships with international
companies that are willing to pa big money,
increase the cash flow, and therefore increase
our share price and investment values
accordingly
Add to My Watchlist
What is My Watchlist?